Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced Genedata SelectorTM, a new solution for biotechnological strain development in fermentation-based applications. The latest addition to the Genedata portfolio, Genedata Selector is an integrated data management and analysis system specifically for industrial biotechnology R&D. It supports industrial biotechnology production of feed and food additives, fine chemicals, biofuels, and personal care, pharmaceutical, and agrochemical products. Genedata Selector will be featured in poster sessions at the Society for Industrial Microbiology 60th Annual Meeting for which Genedata is a leading sponsor (San Francisco Hyatt Regency Embarcadero; August 1 – 5).
“Genedata Selector is our direct response to the urgent need for an integrated data management and analysis platform supporting industrial biotechnology R&D processes including next-generation sequencing,” noted Dr. Othmar Pfannes, CEO of Genedata. “Industrial biotech R&D is different from, for example, pharmaceutical R&D. It requires highly flexible and dynamic computational solutions, which combine genotyping, phenotyping, screening, sequence analyses, and omics technologies -- areas in which Genedata has years of experience and deep domain expertise. At a time of increased pressure to develop bio-based products and implement sustainable production processes, we believe Genedata is leading the way in innovative solutions that advance this high-growth business field.”
About Genedata Selector
Industrial biotechnology is a rapidly growing industry segment focused on developing new biological-based production methods to replace energy- and resource-consumptive processes. With this innovation comes increased data complexity and data volumes. Integrating next-generation sequencing technology data from strain re-sequencing programs, Genedata Selector is able to handle huge and complex data sets from whole production strain genealogies.
A turnkey solution with a comprehensive, interactive and easy-to-use interface, Genedata Selector version 1.0 is based on a central relational database, and includes features that enable:
Automatic identification and evaluation of mutations conferring production-relevant phenotypes.
Identification of novel metabolic engineering targets by large-scale, cross-strain comparisons.
Systematic identification of mutation hot spots and investigation of combinatorial effects.
Phenotypic-genotype correlation analyses across diverse strain collections and strain genealogies.
Integrated pathway analysis for the identification of complex genetic effects positively influencing production phenotypes.
Integration of experimental data including genome, operon, pathway, transcriptomics, proteomics, and metabolomics.
Species independent applications to all biotech-relevant organisms across all phylogenetic kingdoms including bacteria, fungi, mammalian cell lines or plants.
Integration of public and proprietary genome sequences on to one system.
Genedata transforms data into intelligence with a portfolio of advanced software solutions for drug discovery, industrial biotechnology, and life science research. Used by a majority of the world’s top 50 pharmaceutical companies and leading research organizations, Genedata solutions make research data accessible and understandable, enabling scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Japan, Germany, and the US. www.genedata.com
Marketing & Communications
Phone: +41 61 511 8459
Phone: +1 508 881 3109
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
All product and service names mentioned are the trademarks of their respective companies.
Data sharing and knowledge exchange between scientists, technicians, and process engineers across multiple sites and projects.